Hypera S.A. (OTCMKTS:HYPMY – Get Free Report) reached a new 52-week low during trading on Wednesday . The stock traded as low as $2.64 and last traded at $2.70, with a volume of 10164 shares. The stock had previously closed at $2.88.
Hypera Trading Down 7.4 %
The firm’s fifty day simple moving average is $3.74 and its 200 day simple moving average is $4.70. The company has a market cap of $1.74 billion, a price-to-earnings ratio of 5.23 and a beta of 1.02.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Recommended Stories
- Five stocks we like better than Hypera
- Following Congress Stock Trades
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- 3 Tickers Leading a Meme Stock Revival
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
